Prenylcysteine oxidase 1, an emerging player in atherosclerosis

The research into the pathophysiology of atherosclerosis has considerably increased our understanding of the disease complexity, but still many questions remain unanswered, both mechanistically and pharmacologically. Here, we provided evidence that the pro-oxidant enzyme Prenylcysteine Oxidase 1 (PC...

Descripción completa

Detalles Bibliográficos
Autores principales: Banfi, C., Baetta, R., Barbieri, S. S., Brioschi, M., Guarino, A., Ghilardi, S., Sandrini, L., Eligini, S., Polvani, G., Bergman, O., Eriksson, P., Tremoli, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455616/
https://www.ncbi.nlm.nih.gov/pubmed/34548610
http://dx.doi.org/10.1038/s42003-021-02630-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455616/
https://www.ncbi.nlm.nih.gov/pubmed/34548610
http://dx.doi.org/10.1038/s42003-021-02630-z

Ejemplares similares